Normothermic ex vivo Heart Perfusion Combined With Melatonin Enhances Myocardial Protection in Rat Donation After Circulatory Death Hearts via Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis

ObjectiveThe adoption of hearts from donation after circulatory death (DCD) is a promising approach for the shortage of suitable organs in heart transplantation. However, DCD hearts suffer from serious ischemia/reperfusion injury (IRI). Recent studies demonstrate that nucleotide-binding oligomerizat...

Full description

Bibliographic Details
Main Authors: Jun Lu, Liwei Xu, Zifeng Zeng, Chuqing Xue, Jiale Li, Xiong Chen, Pengyu Zhou, Shaoyan Lin, Yuhui Liao, Xianjin Du, Ronghua Yang, Shaoyi Zheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2021.733183/full
id doaj-ef66cc97e02b46518e3709eb5982e9c2
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Jun Lu
Liwei Xu
Zifeng Zeng
Chuqing Xue
Jiale Li
Xiong Chen
Pengyu Zhou
Shaoyan Lin
Yuhui Liao
Xianjin Du
Ronghua Yang
Shaoyi Zheng
spellingShingle Jun Lu
Liwei Xu
Zifeng Zeng
Chuqing Xue
Jiale Li
Xiong Chen
Pengyu Zhou
Shaoyan Lin
Yuhui Liao
Xianjin Du
Ronghua Yang
Shaoyi Zheng
Normothermic ex vivo Heart Perfusion Combined With Melatonin Enhances Myocardial Protection in Rat Donation After Circulatory Death Hearts via Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis
Frontiers in Cell and Developmental Biology
donation after circulatory death
normothermic ex vivo heart perfusion
melatonin
heart preservation
ischemia/reperfusion injury
pyroptosis
author_facet Jun Lu
Liwei Xu
Zifeng Zeng
Chuqing Xue
Jiale Li
Xiong Chen
Pengyu Zhou
Shaoyan Lin
Yuhui Liao
Xianjin Du
Ronghua Yang
Shaoyi Zheng
author_sort Jun Lu
title Normothermic ex vivo Heart Perfusion Combined With Melatonin Enhances Myocardial Protection in Rat Donation After Circulatory Death Hearts via Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis
title_short Normothermic ex vivo Heart Perfusion Combined With Melatonin Enhances Myocardial Protection in Rat Donation After Circulatory Death Hearts via Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis
title_full Normothermic ex vivo Heart Perfusion Combined With Melatonin Enhances Myocardial Protection in Rat Donation After Circulatory Death Hearts via Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis
title_fullStr Normothermic ex vivo Heart Perfusion Combined With Melatonin Enhances Myocardial Protection in Rat Donation After Circulatory Death Hearts via Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis
title_full_unstemmed Normothermic ex vivo Heart Perfusion Combined With Melatonin Enhances Myocardial Protection in Rat Donation After Circulatory Death Hearts via Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis
title_sort normothermic ex vivo heart perfusion combined with melatonin enhances myocardial protection in rat donation after circulatory death hearts via inhibiting nlrp3 inflammasome-mediated pyroptosis
publisher Frontiers Media S.A.
series Frontiers in Cell and Developmental Biology
issn 2296-634X
publishDate 2021-08-01
description ObjectiveThe adoption of hearts from donation after circulatory death (DCD) is a promising approach for the shortage of suitable organs in heart transplantation. However, DCD hearts suffer from serious ischemia/reperfusion injury (IRI). Recent studies demonstrate that nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome-mediated pyroptosis is a novel target to ameliorate myocardial IRI. Melatonin is shown to inhibit NLRP3 inflammasome-mediated pyroptosis. Therefore, this study is designed to verify the hypothesis that melatonin can protect the heart graft preserved with ex vivo heart perfusion (EVHP) against myocardial IRI via inhibiting NLRP3 inflammasome-mediated pyroptosis in a rat model of DCD.MethodsDonor-heart rats were randomly divided into three groups: (1) Control group: non-DCD hearts were harvested from heart-beating rats and immediately preserved with allogenic blood-based perfusate at constant flow for 105 min in the normothermic EVHP system; (2) DCD-vehicle group; and (3) DCD-melatonin group: rats were subjected to the DCD procedure with 25 min of warm ischemia injury and preserved by the normothermic EVHP system for 105 min. Melatonin (200 μmol/L) or vehicle was perfused in the cardioplegia and throughout the whole EVHP period. Cardiac functional assessment was performed every 30 min during EVHP. The level of oxidative stress, inflammatory response, apoptosis, and NLRP3 inflammasome-mediated pyroptosis of heart grafts submitted to EVHP were evaluated.ResultsTwenty five-minute warm ischemia injury resulted in a significant decrease in the developed pressure (DP), dP/dtmax, and dP/dtmin of left ventricular of the DCD hearts, while the treatment with melatonin significantly increased the DP, dP/dtmax of the left ventricular of DCD hearts compared with DCD-vehicle group. Furthermore, warm ischemia injury led to a significant increase in the level of oxidative stress, inflammatory response, apoptosis, and NLRP3 inflammasome-mediated pyroptosis in the hearts preserved with EVHP. However, melatonin added in the cardioplegia and throughout the EVHP period significantly attenuated the level of oxidative stress, inflammatory response, apoptosis, and NLRP3 inflammasome-mediated pyroptosis compared with DCD-vehicle group.ConclusionEVHP combined with melatonin post-conditioning attenuates myocardial IRI in DCD hearts by inhibiting NLRP3 inflammasome-mediated pyroptosis, which might expand the donor pool by the adoption of transplantable DCD hearts.
topic donation after circulatory death
normothermic ex vivo heart perfusion
melatonin
heart preservation
ischemia/reperfusion injury
pyroptosis
url https://www.frontiersin.org/articles/10.3389/fcell.2021.733183/full
work_keys_str_mv AT junlu normothermicexvivoheartperfusioncombinedwithmelatoninenhancesmyocardialprotectioninratdonationaftercirculatorydeathheartsviainhibitingnlrp3inflammasomemediatedpyroptosis
AT liweixu normothermicexvivoheartperfusioncombinedwithmelatoninenhancesmyocardialprotectioninratdonationaftercirculatorydeathheartsviainhibitingnlrp3inflammasomemediatedpyroptosis
AT zifengzeng normothermicexvivoheartperfusioncombinedwithmelatoninenhancesmyocardialprotectioninratdonationaftercirculatorydeathheartsviainhibitingnlrp3inflammasomemediatedpyroptosis
AT chuqingxue normothermicexvivoheartperfusioncombinedwithmelatoninenhancesmyocardialprotectioninratdonationaftercirculatorydeathheartsviainhibitingnlrp3inflammasomemediatedpyroptosis
AT jialeli normothermicexvivoheartperfusioncombinedwithmelatoninenhancesmyocardialprotectioninratdonationaftercirculatorydeathheartsviainhibitingnlrp3inflammasomemediatedpyroptosis
AT xiongchen normothermicexvivoheartperfusioncombinedwithmelatoninenhancesmyocardialprotectioninratdonationaftercirculatorydeathheartsviainhibitingnlrp3inflammasomemediatedpyroptosis
AT pengyuzhou normothermicexvivoheartperfusioncombinedwithmelatoninenhancesmyocardialprotectioninratdonationaftercirculatorydeathheartsviainhibitingnlrp3inflammasomemediatedpyroptosis
AT shaoyanlin normothermicexvivoheartperfusioncombinedwithmelatoninenhancesmyocardialprotectioninratdonationaftercirculatorydeathheartsviainhibitingnlrp3inflammasomemediatedpyroptosis
AT yuhuiliao normothermicexvivoheartperfusioncombinedwithmelatoninenhancesmyocardialprotectioninratdonationaftercirculatorydeathheartsviainhibitingnlrp3inflammasomemediatedpyroptosis
AT xianjindu normothermicexvivoheartperfusioncombinedwithmelatoninenhancesmyocardialprotectioninratdonationaftercirculatorydeathheartsviainhibitingnlrp3inflammasomemediatedpyroptosis
AT ronghuayang normothermicexvivoheartperfusioncombinedwithmelatoninenhancesmyocardialprotectioninratdonationaftercirculatorydeathheartsviainhibitingnlrp3inflammasomemediatedpyroptosis
AT shaoyizheng normothermicexvivoheartperfusioncombinedwithmelatoninenhancesmyocardialprotectioninratdonationaftercirculatorydeathheartsviainhibitingnlrp3inflammasomemediatedpyroptosis
_version_ 1717815867073363968
spelling doaj-ef66cc97e02b46518e3709eb5982e9c22021-09-03T22:07:37ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2021-08-01910.3389/fcell.2021.733183733183Normothermic ex vivo Heart Perfusion Combined With Melatonin Enhances Myocardial Protection in Rat Donation After Circulatory Death Hearts via Inhibiting NLRP3 Inflammasome-Mediated PyroptosisJun Lu0Liwei Xu1Zifeng Zeng2Chuqing Xue3Jiale Li4Xiong Chen5Pengyu Zhou6Shaoyan Lin7Yuhui Liao8Xianjin Du9Ronghua Yang10Shaoyi Zheng11Department of Cardiovascular Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaDepartment of Cardiovascular Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaDepartment of Cardiovascular Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaDepartment of Cardiovascular Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaDepartment of Cardiovascular Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaDepartment of Cardiovascular Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaDepartment of Cardiovascular Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaDepartment of Cardiovascular Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaMolecular Diagnosis and Treatment Center for Infectious Diseases, Dermatology Hospital, Southern Medical University, Guangzhou, ChinaDepartment of Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, ChinaDepartment of Burn Surgery, The First People’s Hospital of Foshan, Foshan, ChinaDepartment of Cardiovascular Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaObjectiveThe adoption of hearts from donation after circulatory death (DCD) is a promising approach for the shortage of suitable organs in heart transplantation. However, DCD hearts suffer from serious ischemia/reperfusion injury (IRI). Recent studies demonstrate that nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome-mediated pyroptosis is a novel target to ameliorate myocardial IRI. Melatonin is shown to inhibit NLRP3 inflammasome-mediated pyroptosis. Therefore, this study is designed to verify the hypothesis that melatonin can protect the heart graft preserved with ex vivo heart perfusion (EVHP) against myocardial IRI via inhibiting NLRP3 inflammasome-mediated pyroptosis in a rat model of DCD.MethodsDonor-heart rats were randomly divided into three groups: (1) Control group: non-DCD hearts were harvested from heart-beating rats and immediately preserved with allogenic blood-based perfusate at constant flow for 105 min in the normothermic EVHP system; (2) DCD-vehicle group; and (3) DCD-melatonin group: rats were subjected to the DCD procedure with 25 min of warm ischemia injury and preserved by the normothermic EVHP system for 105 min. Melatonin (200 μmol/L) or vehicle was perfused in the cardioplegia and throughout the whole EVHP period. Cardiac functional assessment was performed every 30 min during EVHP. The level of oxidative stress, inflammatory response, apoptosis, and NLRP3 inflammasome-mediated pyroptosis of heart grafts submitted to EVHP were evaluated.ResultsTwenty five-minute warm ischemia injury resulted in a significant decrease in the developed pressure (DP), dP/dtmax, and dP/dtmin of left ventricular of the DCD hearts, while the treatment with melatonin significantly increased the DP, dP/dtmax of the left ventricular of DCD hearts compared with DCD-vehicle group. Furthermore, warm ischemia injury led to a significant increase in the level of oxidative stress, inflammatory response, apoptosis, and NLRP3 inflammasome-mediated pyroptosis in the hearts preserved with EVHP. However, melatonin added in the cardioplegia and throughout the EVHP period significantly attenuated the level of oxidative stress, inflammatory response, apoptosis, and NLRP3 inflammasome-mediated pyroptosis compared with DCD-vehicle group.ConclusionEVHP combined with melatonin post-conditioning attenuates myocardial IRI in DCD hearts by inhibiting NLRP3 inflammasome-mediated pyroptosis, which might expand the donor pool by the adoption of transplantable DCD hearts.https://www.frontiersin.org/articles/10.3389/fcell.2021.733183/fulldonation after circulatory deathnormothermic ex vivo heart perfusionmelatoninheart preservationischemia/reperfusion injurypyroptosis